首页> 美国卫生研究院文献>The Journal of Neuroscience >Phenotype of Striatofugal Medium Spiny Neurons in Parkinsonian and Dyskinetic Nonhuman Primates: A Call for a Reappraisal of the Functional Organization of the Basal Ganglia
【2h】

Phenotype of Striatofugal Medium Spiny Neurons in Parkinsonian and Dyskinetic Nonhuman Primates: A Call for a Reappraisal of the Functional Organization of the Basal Ganglia

机译:帕金森病和运动障碍非人类灵长类动物的纹状体中棘神经元表型:呼吁重新评估基底神经节的功能组织。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The classic view of anatomofunctional organization of the basal ganglia is that striatopallidal neurons of the “indirect” pathway express D2 dopamine receptors and corelease enkephalin with GABA, whereas striatopallidal neurons of the “direct” pathway bear D1 dopamine receptors and corelease dynorphin and substance P with GABA. Although many studies have investigated the pathophysiology of the basal ganglia after dopamine denervation and subsequent chronic levodopa (l-dopa) treatment, none has ever considered the possibility of plastic changes leading to profound reorganization and/or biochemical phenotype modifications of medium spiny neurons. Therefore, we studied the phenotype of striatal neurons in four groups of nonhuman primates, including the following: normal, parkinsonian, parkinsonian chronically treated with l-dopa without exhibiting dyskinesia, and parkinsonian chronically treated with l-dopa exhibiting overt dyskinesia. To identify striatal cells projecting to external (indirect) or internal (direct) segments of the globus pallidus, the retrograde tracer cholera toxin subunit B (CTb) was injected stereotaxically into the terminal areas. Using immunohistochemistry techniques, brain sections were double labeled for CTb and dopamine receptors, opioid peptides, or the substance P receptor (NK1). We also used HPLC-RIA to assess opioid levels throughout structures of the basal ganglia. Our results suggest that medium spiny neurons retain their phenotype because no variations were observed in any experimental condition. Therefore, it appears unlikely that dyskinesia is related to a phenotype modification of the striatal neurons. However, this study supports the concept of axonal collateralization of striatofugal cells that project to both globus pallidus pars externa and globus pallidus pars interna. Striatofugal pathways are not as segregated in the primate as previously considered.
机译:基底神经节的解剖功能组织的经典观点是,“间接”途径的纹状体神经节神经元表达D2多巴胺受体并与GABA共释放脑啡肽,而“直接”途径的纹状体神经节神经元则具有D1多巴胺受体,并与强啡肽和P物质共释放GABA。尽管许多研究已经研究了多巴胺去神经和随后的慢性左旋多巴(l-dopa)治疗后基底神经节的病理生理学,但还没有人考虑过塑性改变导致中度多刺神经元发生深刻重组和/或生化表型修饰的可能性。因此,我们研究了四组非人类灵长类动物的纹状体神经元的表型,包括以下几类:正常,帕金森病,长期用l-多巴治疗的帕金森病,没有表现出运动障碍,以及帕金森氏症长期用l-多巴治疗的表现为明显的运动障碍。为了鉴定出投射到苍白球外部(间接)或内部(直接)部分的纹状体细胞,将逆行示踪剂霍乱毒素亚基B(CTb)立体定位注入末端区域。使用免疫组织化学技术,将脑部的CTb和多巴胺受体,阿片肽或P物质(NK1)双重标记。我们还使用HPLC-RIA评估整个基底神经节结构中的阿片类药物水平。我们的结果表明中棘状神经元保留其表型,因为在任何实验条件下均未观察到变异。因此,运动障碍似乎与纹状体神经元的表型修饰无关。但是,这项研究支持了投射到苍白球和内部苍白球的纹状体真菌细胞的轴突抵押的概念。条纹状真菌途径在灵长类动物中的分离程度不如先前考虑的那样。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号